2 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 2 of 2 clinical reviews.
Weight gain wasn't a distinct adverse event in Dayvigo trials; somnolence was most common, at 10% (5mg) to 22% (10mg). See full incidence data by dose.
Case reports link lemborexant to euphoria and laughter alongside rarer risks like complex sleep behaviors and hallucinations. See what the evidence shows.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.